BERNARDI, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 163.746
AS - Asia 16.614
EU - Europa 13.037
SA - Sud America 2.124
Continente sconosciuto - Info sul continente non disponibili 715
AF - Africa 157
OC - Oceania 28
AN - Antartide 1
Totale 196.422
Nazione #
US - Stati Uniti d'America 163.097
SG - Singapore 8.906
CN - Cina 3.241
UA - Ucraina 2.427
DE - Germania 2.150
BR - Brasile 1.712
RU - Federazione Russa 1.670
HK - Hong Kong 1.501
IE - Irlanda 1.296
IT - Italia 1.263
FR - Francia 1.044
VN - Vietnam 974
SE - Svezia 795
GB - Regno Unito 680
PL - Polonia 630
FI - Finlandia 596
KR - Corea 479
BD - Bangladesh 445
JP - Giappone 359
CA - Canada 286
IN - India 160
AR - Argentina 143
NL - Olanda 105
MX - Messico 93
BE - Belgio 76
ID - Indonesia 71
ES - Italia 64
EC - Ecuador 61
CO - Colombia 59
TR - Turchia 57
IQ - Iraq 56
CR - Costa Rica 55
JM - Giamaica 55
EU - Europa 51
ZA - Sudafrica 50
VE - Venezuela 47
AT - Austria 45
CL - Cile 37
UZ - Uzbekistan 34
KG - Kirghizistan 33
PK - Pakistan 33
CZ - Repubblica Ceca 29
HN - Honduras 28
MA - Marocco 28
SA - Arabia Saudita 28
NI - Nicaragua 27
MY - Malesia 26
TT - Trinidad e Tobago 26
AU - Australia 25
AE - Emirati Arabi Uniti 24
IL - Israele 23
PH - Filippine 23
GT - Guatemala 22
PY - Paraguay 22
RO - Romania 20
CH - Svizzera 18
EG - Egitto 18
LT - Lituania 18
UY - Uruguay 18
KE - Kenya 15
NP - Nepal 15
PE - Perù 15
TN - Tunisia 15
DK - Danimarca 13
IR - Iran 13
JO - Giordania 13
KZ - Kazakistan 12
TH - Thailandia 12
AZ - Azerbaigian 11
BG - Bulgaria 11
GR - Grecia 11
PR - Porto Rico 11
PT - Portogallo 11
AL - Albania 10
DM - Dominica 10
EE - Estonia 10
GE - Georgia 10
OM - Oman 10
SV - El Salvador 10
DZ - Algeria 8
RS - Serbia 7
BH - Bahrain 6
CI - Costa d'Avorio 6
LB - Libano 6
LV - Lettonia 6
MT - Malta 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
HR - Croazia 5
NG - Nigeria 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BS - Bahamas 4
GY - Guiana 4
KH - Cambogia 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
BZ - Belize 3
CG - Congo 3
Totale 195.698
Città #
Woodbridge 49.574
Wilmington 39.415
Houston 36.544
Fairfield 4.888
Ann Arbor 4.138
Ashburn 3.650
Singapore 3.387
Jacksonville 2.254
Seattle 1.995
San Jose 1.917
Cambridge 1.615
Hong Kong 1.486
Chandler 1.396
Dublin 1.293
Beijing 1.070
Medford 978
Santa Clara 643
Dearborn 602
Council Bluffs 592
Kraków 576
The Dalles 537
New York 524
Lawrence 465
Los Angeles 408
Zhengzhou 368
Mülheim 349
Ho Chi Minh City 313
Buffalo 301
Tokyo 278
Moscow 268
Hangzhou 264
San Diego 244
Rome 230
Hanoi 229
Menlo Park 223
Dallas 178
Milan 176
São Paulo 169
Lauterbourg 167
Falls Church 133
Munich 115
Helsinki 109
Chicago 107
University Park 103
Shanghai 101
London 100
Mountain View 100
San Mateo 98
Verona 91
Detroit 90
Norwalk 87
Orem 84
Atlanta 81
Brooklyn 78
Guangzhou 78
North Bergen 77
Hefei 74
Redwood City 71
Boardman 69
Toronto 67
Denver 66
Mcallen 64
Montreal 62
Phoenix 60
Brussels 58
Palo Alto 58
Nanjing 55
Rio de Janeiro 55
Chennai 48
Redondo Beach 48
Saint Petersburg 48
Brasília 46
Carrboro 46
Naples 46
San Francisco 44
San José 41
Columbus 40
Nuremberg 40
Frankfurt am Main 39
Warsaw 39
Haiphong 38
Miami 38
Da Nang 37
Dhaka 37
Nürnberg 36
Stockholm 35
Boston 34
Kunming 34
Philadelphia 33
Belo Horizonte 32
Jakarta 32
Kingston 32
Johannesburg 31
Porto Alegre 30
Manchester 29
St Louis 29
Amsterdam 28
Washington 28
New Orleans 27
Campinas 26
Totale 167.266
Nome #
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression 747
Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia 629
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis 628
TRPV1 channels facilitate glutamate transmission in the striatum 621
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis 620
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 617
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 614
Spastic paraplegia, epilepsy, and mental retardation in several members of a family: a novel genetic disorder 591
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 589
Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the 'indirect pathway' 581
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 578
Reduced GABA Content in the Motor Thalamus during effective deep brain stimulation of the subthalamic nucleus 567
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 564
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 561
The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients 550
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 540
Leukocyte aggregation in patients with a previous cerebral ischemic event 536
Connectivity Between Posterior Parietal Cortex and Ipsilateral Motor Cortex Is Altered in Schizophrenia 533
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein 531
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 529
Adjuvant pneumomediastinum in thoracoscopic thymectomy for myasthenia gravis 528
Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine 528
Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation 527
A continuous high frequency stimulation of the subthalamic nucleus determines a suppression of excitatory synaptic transmission in nigral dopaminergic neurons recorded in vitro 521
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism 520
Spontaneous sleep modulates the firing pattern of Parkinsonian subthalamic nucleus 519
The myotonic dystrophy type 2 (DM2) gene product zinc finger protein 9 (ZNF9) is associated with sarcomeres and normally localized in DM2 patients' muscles 516
Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot-Marie-Tooth disease type 1A 515
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 515
Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human CU/ZN superoxide dismutase (GLY(93)-->ALA) mutation 513
Subacute demyelinating polyneuropathy in B-cell lymphoma with IgM antibodies against glycolipid GD1b 512
Video-assisted complete thymectomy in the treatment of autoimmune myasthenia [Timectomia estesa video-assistita nel trattamento della miastenia autoimmune] 508
Clinical and genetic study of a large SPG4 Italian family 507
Manganese intoxication decreases the expression of manganoproteins in the rat basal ganglia: an immunohistochemical study. 507
Inhibition of persistent sodium current fraction and voltage-gated L-type calcium current by propofol in cortical neurons: Implications for its antiepileptic activity 506
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 505
Differences in the neurotoxicity profile induced by ATP and ATPgammaS in cultured cerebellar granule neurons 502
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 501
TRPV1 channels regulate cortical excitability in humans 501
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 500
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 500
The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie 500
Video-assisted completion thymectomy in refractory myasthenia gravis 499
Up-regulation of P2X(2), P2X(4) receptor and ischemic cell death: Prevention by P2 antagonists 499
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 497
Serial determinations of leukocyte aggregation in patients with ischemic stroke 496
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus. 496
Synaptic transmission in the striatum: from plasticity to neurodegeneration 495
Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study 495
Age-related functional changes of high-voltage-activated calcium channels in different neuronal subtypes of mouse striatum 494
Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment 492
Differential distribution of nicotinamide adenine dinucleotide phosphate-diaphorase and neural nitric oxide synthase in the rat choroid plexus. A histochemical and immunocytochemical study 490
Left thoracoscopic approach to the thymus in myasthenic patients 489
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 489
Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats An electron spectroscopy imaging and electron energy-loss spectroscopy study. 489
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 487
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 486
The effect of levodopa therapy on dopamine transporter SPECT imaging with 123I-FP-CIT in patients with Parkinson's disease 484
Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients 484
Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes 484
Muscarinic IPSPs in rat striatal cholinergic interneurones 483
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 483
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 483
Increased levels of p70S6 phosphorylation in the G93A mouse model of Amyotrophic Lateral Sclerosis and in valine-exposed cortical neurons in culture 483
P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat 482
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease 482
Resistance to striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice expressing human mutant Cu,Zn superoxide dismutase 481
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 480
Thoracoscopic thymectomy in autoimmune myasthenia: Results of left-sided approach 480
Role of the metabotropic P2Y(4) receptor during hypoglycemia: cross talk with the ionotropic NMDAR1 receptor 480
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 479
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 479
Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum 479
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 478
Altered vulnerability to kainate excitotoxicity of transgenic-Cu/Zn SOD1 neurones 478
Distinct roles of group I mGlu receptors in striatal function 478
SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status 478
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids 478
Difficulty diagnosing chronic cryptococcal meningitis in idiopathic CD4+ lymphocytopenia 477
Upper motor neuron involvement in X-linked recessive bulbospinal muscular atrophy 477
Early subclinical cochlear dysfunction in myotonic dystrophy type 1. 477
Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans 476
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 476
Voltage-activated sodium currents in a cell line expressing a Cu,Zn superoxide dismutase typical of familial ALS 476
Subcellular localization of the myotonic dystrophy type 2 protein ZNF9 in skeletal muscle 476
Sural nerve without nerve fibers in leprous neuropathy 476
Distinguishing forms of generalized epilepsy using magnetic brain stimulation 475
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 475
Serial determinations of leukocyte aggregation in patients with ischemic stroke 475
PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology 475
Hippocampus versus entorhinal cortex decoupling by an NR2 subunit-specific block of NMDA receptors in a rat in vitro model of temporal lobe epilepsy 475
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 474
The Project for a Scientific Psychology (1895): a Freudian anticipation of LTP-memory connection theory 473
Migraine-like disorder segregating with mtDNA 14484 Leber hereditary optic neuropathy mutation 473
Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis 472
Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes 472
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 472
Dystrophin is not essential for the integrity of the cytoskeleton 472
Neurophysiology of Parkinson's disease: from basic research to clinical correlates 472
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 471
Totale 50.903
Categoria #
all - tutte 420.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 420.691


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.634 0 0 0 251 139 549 213 193 287 475 192 1.335
2022/20234.612 564 284 99 497 322 1.282 418 218 354 13 454 107
2023/20241.293 140 45 109 27 113 378 60 89 19 17 13 283
2024/202511.886 306 2.422 1.129 530 216 654 669 365 824 611 2.365 1.795
2025/202614.588 1.121 827 1.796 1.135 1.220 517 1.572 1.968 1.671 1.481 698 582
2026/20276.443 891 854 3.024 1.674 0 0 0 0 0 0 0 0
Totale 196.422